[vc_row content_placement=”middle” css=”.vc_custom_1646414696274{margin-bottom: 36px !important;}”][vc_column width=”1/2″][vc_column_text]

The Epilepsy Foundation of Colorado & Wyoming is committed to serving the best interests of people with epilepsy, their family members and caregivers and proudly advocates:

• Funding for epilepsy programs, research, and a cure
• Policies that promote research and innovation
• Improving access to and coverage of quality care and essential services
• The protection of the rights of individuals with disabilities.

These broad goals guide both our federal and state advocacy activities.[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_single_image image=”131″ alignment=”center”][/vc_column][/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1646339308744{background-color: #efedf2 !important;}”][vc_column width=”1/2″][vc_column_text]

Epilepsy Foundation Advocacy Priorities

We are working to secure more funding for a cure, support community-based programs for people living with epilepsy, eradicate stigma and discrimination, and protect patient access to medications and treatment. To learn more about our policy priorities, visit https://www.epilepsy.com/about-us/advocacy/advocacy-priorities.[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]

The Epilepsy Foundation supports funding increases for epilepsy research at the National Institutes of Health (NIH); epilepsy programs at the Centers for Disease Control and Prevention (CDC) focused on building safer communities for people living with epilepsy; and promoting safety, efficacy and research at the Food and Drug Administration (FDA).

[/vc_column_text][/vc_column][/vc_row][vc_row css=”.vc_custom_1646414708906{margin-top: 36px !important;}”][vc_column][vc_column_text css=””]

Access to Care

Timely access to appropriate care and effective coverage for epilepsy medications is a critical concern for people living with epilepsy, because epilepsy medications are the most common and most cost-effective treatment for controlling and/or reducing seizures. Individuals living with epilepsy who experience a delay in accessing their medication due to prior authorization and step therapy requirements, high cost-sharing, medication substitutions without physician and patient consent, and onerous drug monitoring requirements, are at a high risk for developing breakthrough seizures and related complications, including Sudden Unexpected Death in Epilepsy (SUDEP). Learn more about our advocacy on access to care issues.[/vc_column_text][/vc_column][/vc_row][vc_row content_placement=”middle”][vc_column width=”1/2″][vc_single_image image=”164″ alignment=”center”][/vc_column][vc_column width=”1/2″][vc_column_text]

Research and Innovation

Innovation is of particular importance to the nearly one million people living with epilepsy who don’t have their seizures under control and are seeking new treatments and a cure, as well as many Americans living with complex chronic and rare conditions that are not appropriately managed with current treatment options. Learn more. [/vc_column_text][/vc_column][/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1646339427842{padding-bottom: 24px !important;background-color: #efedf2 !important;}”][vc_column][vc_column_text]

Disability and Discrimination

Stigma surrounding epilepsy continues to fuel discrimination and isolates people with epilepsy from the mainstream of life. Despite great progress in recent years, epilepsy remains a formidable barrier to educational opportunities, employment, and personal fulfillment among older children and adults. Learn more about the Epilepsy Foundation’s disability and discrimination advocacy.[/vc_column_text][/vc_column][/vc_row]